Pfizer's Intellectual Property Rights Battles in China for Viagra


IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
 
Case Studies | Case Study in Business, Management, Operations, Strategy, Case Study

ICMR HOME | Case Studies Collection

Case Details:

Case Code : BENV010
Case Length : 22 Pages
Period : 2000-2007
Pub Date : 2007
Teaching Note :Not Available
Organization : Pfizer, Inc.
Industry : Pharmaceutical
Countries : China

To download Pfizer's Intellectual Property Rights Battles in China for Viagra case study (Case Code: BENV010) click on the button below, and select the case from the list of available cases:

Business Environment Case Studies | Case Study in Management, Operations, Strategies, Business Environment, Case Studies



Price:

For delivery in electronic format: Rs. 300;
For delivery through courier (within India): Rs. 300 + Rs. 25 for Shipping & Handling Charges

Business Environment Case Studies
Business Environment Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies



Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.

<< Previous

Excerpts Contd...

Pfizer's Viagra Patent Restored

In late 2004, Pfizer sued SIPO's PRB for wrongfully invalidating its patent for Viagra. It appealed to the court to withdraw the PRB's decision. The case was argued in March 2005. Pfizer's attorney, Tai Hong (Hong), argued before the court that Pfizer had provided the information that was needed for granting of the patent.

She said, "The decision made by the PRB had errors in facts and [was an] erroneous application of the law."Hong also argued that SIPO's decision violated the TRIPS agreements. She also hinted that the right decision was not reached because the attorney applying for invalidation of the patent, Xu Guowen, was a retired official with the PRB...

China Cracks Down on Counterfeiters

In November 2006, the Chinese government cracked down on Viagra counterfeiters. A Chinese man, Xi Yongli (Yongli), was jailed for eight years for producing 60 tonnes of fake pills for ED. It was alleged that Yongli and his accomplices had sold pills worth 21.8 million yuan ($3.6 million) under the names, America Number One, Male Exclusive, Great Big Brother...

Pfizer Loses Viagra Trademark Row

When Pfizer launched Viagra in China it could not use the popular Chinese equivalent brand name 'Wei Ge' as the name was already registered by Guangzhou Viaman Pharmaceutical Co Ltd (Viaman). Viaman had registered this brand name in 1998, when Pfizer launched Viagra in the US. Viaman produced another ED drug by the name 'Wei Ge' containing the ingredient Phentolamine mesylate...

Outlook

Experts felt that the Chinese patent law and its market had matured considerably in a relatively short span of time. However, they felt that China still was lagging behind in providing a credible patent enforcement system. Experts were not too optimistic about the impact of the ruling on Viagra's global sales. Even with exclusive rights, Viagra's sales in China was not expected to change Viagra's global sales significantly as the brand was facing worldwide decline in sales and tough competition from Levitra and especially Cialis...

Exhibits

Exhibit I: A Brief Note on Pfizer
Exhibit II: Viagra's Timeline: From Chance Discovery to Commercial Success
Exhibit III: Global Sales of Viagra
Exhibit IV: Viagra in China - A Timeline
Exhibit V: A Brief Note on China's Patent Laws
Exhibit VI: Chinese Pharmaceutical Market: Some Facts
Exhibit VII: The Booming Chinese Pharmaceutical Market (US$ Billion)
Exhibit VIII: The Top Seven Pharmaceutical Companies in China


 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.